These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 9817526)

  • 21. Management of community-acquired pneumonia in the era of pneumococcal resistance: a report from the Drug-Resistant Streptococcus pneumoniae Therapeutic Working Group.
    Heffelfinger JD; Dowell SF; Jorgensen JH; Klugman KP; Mabry LR; Musher DM; Plouffe JF; Rakowsky A; Schuchat A; Whitney CG
    Arch Intern Med; 2000 May; 160(10):1399-408. PubMed ID: 10826451
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Determination of penicillin resistance in Streptococcus pneumoniae and use of co-trimoxazole in treatment of pneumococcal pneumoniae.
    Lalitha MK; Manoharan A; Pai R; Thomas K
    J Clin Microbiol; 1999 Aug; 37(8):2743-4. PubMed ID: 10447408
    [No Abstract]   [Full Text] [Related]  

  • 23. [In vitro activity of pristinamycin on respiratory bacteria].
    Leclercq R
    Presse Med; 1999 Sep; 28 Suppl 1():6-9. PubMed ID: 10506876
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Clinical relevance of antimicrobial resistance in the management of pneumococcal community-acquired pneumonia.
    Feldman C
    J Lab Clin Med; 2004 May; 143(5):269-83. PubMed ID: 15122171
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Resistant pneumococcus].
    Manresa F
    Arch Bronconeumol; 1997 Sep; 33(8):367-8. PubMed ID: 9376934
    [No Abstract]   [Full Text] [Related]  

  • 26. Treatment of pneumococcal pneumonia.
    Pallares R
    Semin Respir Infect; 1999 Sep; 14(3):276-84. PubMed ID: 10501315
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Antimicrobial susceptibility of Streptococcus pneumoniae isolates from vaccinated and non-vaccinated patients with a clinically confirmed diagnosis of community-acquired pneumonia in Belgium.
    Lismond A; Carbonnelle S; Verhaegen J; Schatt P; De Bel A; Jordens P; Jacobs F; Dediste A; Verschuren F; Huang TD; Tulkens PM; Glupczynski Y; Van Bambeke F
    Int J Antimicrob Agents; 2012 Mar; 39(3):208-16. PubMed ID: 22245497
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [A child with pneumonia caused by a multiresistant pneumococcus].
    Verhoef-Verhage EA; Fleer A
    Ned Tijdschr Geneeskd; 1990 Apr; 134(15):770-2. PubMed ID: 2336115
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Risk Factors for Community-Onset Pneumonia Caused by Levofloxacin-Nonsusceptible Streptococcus pneumoniae.
    Seok H; Kang CI; Huh K; Cho SY; Ha YE; Chung DR; Peck KR
    Microb Drug Resist; 2018 Nov; 24(9):1412-1416. PubMed ID: 29565225
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Hidden epidemic of macrolide-resistant pneumococci.
    Klugman KP; Lonks JR
    Emerg Infect Dis; 2005 Jun; 11(6):802-7. PubMed ID: 15963272
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Fatal infection with chloramphenicol resistant pneumococcus].
    Margaliot S; Reichert N; Rubinstein E
    Harefuah; 1982 Mar; 102(5):197-8. PubMed ID: 7117946
    [No Abstract]   [Full Text] [Related]  

  • 32. Influence of penicillin resistance on outcome in adult patients with invasive pneumococcal pneumonia: is penicillin useful against intermediately resistant strains?
    Falcó V; Almirante B; Jordano Q; Calonge L; del Valle O; Pigrau C; Planes AM; Gavaldà J; Pahissa A
    J Antimicrob Chemother; 2004 Aug; 54(2):481-8. PubMed ID: 15215226
    [TBL] [Abstract][Full Text] [Related]  

  • 33. In vitro activity of ertapenem against bacteraemic pneumococci: report of a French multicentre study including 339 strains.
    Decousser JW; Methlouthi I; Pina P; Allouch P;
    J Antimicrob Chemother; 2005 Mar; 55(3):396-8. PubMed ID: 15705639
    [No Abstract]   [Full Text] [Related]  

  • 34. Bacteremic pneumonia due to multidrug-resistant pneumococci in 3 patients treated unsuccessfully with azithromycin and successfully with levofloxacin.
    Fogarty C; Goldschmidt R; Bush K
    Clin Infect Dis; 2000 Aug; 31(2):613-5. PubMed ID: 10987733
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The comparative development of elevated resistance to macrolides in community-acquired pneumonia caused by Streptococcus pneumoniae.
    Yayan J
    Drug Des Devel Ther; 2014; 8():1733-43. PubMed ID: 25336917
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Novel streptogramin antibiotics.
    Bonfiglio G; Furneri PM
    Expert Opin Investig Drugs; 2001 Feb; 10(2):185-98. PubMed ID: 11178336
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Role of beta-lactam agents in the treatment of community-acquired pneumonia.
    Garau J
    Eur J Clin Microbiol Infect Dis; 2005 Feb; 24(2):83-99. PubMed ID: 15696306
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Question 3: can pneumonia caused by penicillin-resistant Streptococcus pneumoniae be treated with penicillin?
    Clifford V; Tebruegge M; Vandeleur M; Curtis N
    Arch Dis Child; 2010 Jan; 95(1):73-7. PubMed ID: 20040690
    [No Abstract]   [Full Text] [Related]  

  • 39. Streptococcus pneumoniae: epidemiology and patterns of resistance.
    Jacobs MR
    Am J Med; 2004 Aug; 117 Suppl 3A():3S-15S. PubMed ID: 15360092
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Hospitalized community-acquired pneumonia due to Streptococcus pneumoniae: Has resistance to antibiotics decreased?
    Vallès X; Marcos A; Pinart M; Piñer R; Marco F; Mensa JM; Torres A
    Chest; 2006 Sep; 130(3):800-6. PubMed ID: 16963678
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.